5 January 2015 in Cardiovascular Research
Crosstalk between cardiomyocytes and fibroblasts in physiological conditions and during disease remains poorly defined. Previous studies have shown that fibroblasts and myocytes interact via paracrine communication, but several experimental confounding factors, including the use of immature myocytes and the induction of alpha-smooth muscle actin (α-SMA) expression in fibroblasts by prolonged culture, have hindered our understanding of this phenomenon. We hypothesize that fibroblasts and myofibroblasts differentially affect cardiomyocytes viability, volume, and Ca2+ handling via soluble mediators. More specifically here: (i) we compare the effects of freshly isolated fibroblasts and cultured fibroblasts from normal rat hearts on adult cardiomyocytes; (ii) we compare the effects of (freshly isolated) normal fibroblasts and myofibroblasts from pressure-overloaded hearts; and (iii) we study the contribution of TGF-β and the importance of the crosstalk between the two cell types. We used co-culture methods and conditioned medium to investigate paracrine interaction between fibroblasts and cardiomyocytes. All fibroblast types reduce cardiomyocyte viability and increase cardiomyocyte volume but α-SMA-negative fibroblasts increase cardiomyocyte Ca2+ transient amplitude, whereas cultured fibroblasts and myofibroblasts from pressure-overloaded hearts decrease Ca2+ transient amplitude. In turn, cardiomyocytes release soluble mediators that affect fibroblast proliferation. Using SB431542 to block TGF-β type 1 receptors, we determined that TGF-β directly causes cardiomyocyte hypertrophy and participates in bi-directional regulatory signalling between fibroblasts and cardiomyocytes. Fibroblasts have different roles during physiology and disease in regulating myocardial function via soluble mediators. A crosstalk between fibroblasts and cardiomyocytes, controlled by TGF-β, is crucial in this interaction.
1 January 2015 in Biophysical Journal
1 January 2016 in Biophysical Journal
1 December 2015 in Journal of Molecular and Cellular Cardiology
9 June 2022 in European Heart Journal - Cardiovascular Imaging
A 61-year-old male presented with an out-of-hospital VF arrest. Coronary angiography identified critical mid-vessel stenosis of the left anterior descending artery, which received stenting, and moderate proximal bystander disease in the right coronary artery (RCA) (Panel A). Initial echocardiography was suggestive of hypertrophic cardiomyopathy, noting a thickened intraventricular septum. Cardiac MRI (cMRI), however, identified a large mass in the right atrioventricular groove and right ventricular (RV) free wall, and a mass in the intraventricular septum (Panels B–D, see Supplementary data online, Video S1), both showing high T2 signal intensity (Panel E). There was a prominent coronary vessel floating sign (arrows), characteristic of malignant lymphoma. The RCA was entirely encased in the mass, reflecting its appearance on angiography. Cardiac 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) demonstrated heterogeneous signal uptake correlating with the areas of infiltration identified on cMRI (Panel F). RV biopsy confirmed...